{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:10:31Z","timestamp":1794053431007,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","award":["8102758105"],"award-info":[{"award-number":["8102758105"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["glob health res policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The contribution of vaccination to global public health and community wellbeing has been described as one of the greatest success stories of modern medicine. However, 13.5 million children still miss at least one of their routine vaccinations, and this contributes to about 1.5 million deaths from vaccine-preventable diseases. One of the contributing factors has been associated with vaccine hesitancy. Vaccine hesitancy is the delay or refusal of vaccines despite their availability. The study explored factors from multiple perspectives that influence hesitancy among caregivers of children and adolescent girls eligible for childhood routine immunisation and the Human Papillomavirus vaccine in Malawi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The methodology used was qualitative such as key informant interviews and focus-group discussion. Information was obtained from caregivers, community and religious leaders, leaders of civil society groups, teachers in schools where Human Papillomavirus vaccine were piloted, healthcare workers, national and district-level officials of the expanded program on immunisation. There were 25 key informant interviews and two focus-group discussions, with 13 participants. The study was conducted between April to May 2020. The Interviews and discussions were audio-recorded, transcribed, and analysed using a thematic content approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most vaccine-hesitancy drivers for routine immunisation were also relevant for the HPV vaccine. The drivers included inadequate awareness of the vaccination schedule, rumours and conspiracy theories exacerbated by religious beliefs, low literacy levels of caregivers, distance and transport to the vaccination clinic, gender role and a disconnect between community healthcare workers and community leaders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study demonstrated that a network of factors determines vaccine hesitancy for childhood Routine Immunisation and Human Papillomavirus, and some of them are interrelated with one another. This has implications both for current levels of vaccine acceptance and the introduction of any new vaccine, such as those against Malaria, HIV\/AIDS, HPV or COVID-19 (coronavirus disease 2019). Therefore, strategies developed to address vaccine hesitancy must be multi-component and wide-ranging.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41256-022-00261-3","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T21:02:19Z","timestamp":1660770139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-0183","authenticated-orcid":false,"given":"Gbadebo Collins","family":"Adeyanju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Betsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdu A.","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijah Sanusi","family":"Gumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristide","family":"Aplogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoua","family":"Tall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tene-Alima","family":"Essoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"261_CR1","unstructured":"World Health Organization (WHO). Immunization coverage. Geneva: 2019a."},{"key":"261_CR2","unstructured":"Vanderslott S, Dadonaite B, Roser M Vaccination. Our world in Data. 2019. retrieved Jan 2, 2020, from https:\/\/ourworldindata.org\/vaccination."},{"key":"261_CR3","unstructured":"World Bank Group, n.d. Sub-Sahara Africa Data. retrieved Dec. 7, 2020, from https:\/\/data.worldbank.org\/country\/ZG."},{"key":"261_CR4","unstructured":"WHO\/UNICEF Estimates of national immunisation coverage (WUENIC). Global immunisation dataset. 2019a. Retrieved Jan 5, 2021; from https:\/\/data.unicef.org\/topic\/child-health\/immunization\/"},{"key":"261_CR5","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.supp.2020.35.1.19096","author":"G Chirwa","year":"2020","unstructured":"Chirwa G, Wilkins KA, Mercer DJ. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi. Pan Afr Med J. 2020. https:\/\/doi.org\/10.11604\/pamj.supp.2020.35.1.19096.","journal-title":"Pan Afr Med J"},{"key":"261_CR6","unstructured":"Malawi Ministry of Health (MOH). HPV vaccine demonstration project evaluation in malawi; technical report. Available online: https:\/\/www.msh.org\/search?keywords=HPV%20Vaccine%20Demonstration%20Project%20Evaluation%20in%20Malawi (Retrieved Dec. 8, 2020)."},{"key":"261_CR7","unstructured":"Malawi Ministry of Health (MOH). Malawi national routine immunization Data 2019; Unpublished, Lilongwe, Malawi. Available online: https:\/\/www.humanitarianresponse.info\/sites\/www.humanitarianresponse.info\/files\/documents\/files\/2021_final_pdf-covid_19_vaccine_deployment_for_malawi_2.pdf (Retrieved on 20 Jan 2020)."},{"key":"261_CR8","unstructured":"WHO\/Strategic Advisory Working Group (SAGE) on vaccination hesitancy report, 2014. Retrieved Dec 28, 2019. https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/SAGE_working_group_revised_report_vaccine_hesitancy.pdf"},{"key":"261_CR9","unstructured":"WHO: Ten threats to Global Health in 2019. 2019b. Retrieved Oct 17, 2020, from World Health Organization. https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in- 2019"},{"key":"261_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12889-017-4526-y","volume":"17","author":"KP Msyamboza","year":"2017","unstructured":"Msyamboza KP, Mwagomba BM, Valle M, Chiumia H, Phiri T. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges. BMC Public Health. 2017;17:599. https:\/\/doi.org\/10.1186\/s12889-017-4526-y.","journal-title":"BMC Public Health"},{"issue":"8","key":"261_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4161\/hv.24657","volume":"9","author":"E Dub\u00e9","year":"2013","unstructured":"Dub\u00e9 E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763\u201373. https:\/\/doi.org\/10.4161\/hv.24657.","journal-title":"Hum Vaccin Immunother"},{"key":"261_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ebiom.2016.08.042","volume":"12","author":"HJ Larson","year":"2016","unstructured":"Larson HJ. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295\u2013301. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.042.","journal-title":"EBioMedicine"},{"issue":"2","key":"261_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/archdischild-2020-318988","volume":"106","author":"S Bhopal","year":"2020","unstructured":"Bhopal S, Nielsen M. Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response. Arch Dis Child. 2020;106(2):113\u20134. https:\/\/doi.org\/10.1136\/archdischild-2020-318988.","journal-title":"Arch Dis Child"},{"key":"261_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008145.pub3","author":"A Oyo-Ita","year":"2016","unstructured":"Oyo-Ita A, Wiysonge CS, Oringanje C, Nwachukwu CE, Oduwole O, Meremikwu MM. Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD008145.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"261_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225\u20138. https:\/\/doi.org\/10.1038\/s41591-020-1124-9.","journal-title":"Nat Med"},{"key":"261_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pvr.2017.08.003","volume":"4","author":"C Dochez","year":"2017","unstructured":"Dochez C, Burnett RJ, Mbassi SM, Were F, Musyoki A, Daisy Trovoada M, Mphahlele J. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction. Papillomavirus Res. 2017;4:66\u201371. https:\/\/doi.org\/10.1016\/j.pvr.2017.08.003.","journal-title":"Papillomavirus Res"},{"key":"261_CR17","unstructured":"International agency for research on cancer (IARC) 2018 Report. World Health Organisation Press release No. 263. 2018, Sept. 12. Retrieved Feb. 16, 2021 at https:\/\/www.iarc.who.int\/wp-content\/uploads\/2018\/09\/pr263_E.pdf"},{"key":"261_CR18","unstructured":"Bruni L, Albero G, Serrano B, Mena M, Collado, JJ, G\u00f3mez D, Mu\u00f1oz J, Bosch, FX, de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in Africa. Summary Report. 2018, Dec. 10. https:\/\/hpvcentre.net\/statistics\/reports\/XFX.pdf"},{"issue":"6","key":"261_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"261_CR20","unstructured":"GLOBOCAN 2018: Global Cancer Data: GLOBOCAN 2018. 2018, Sept. 12. Retrieved Dec. 5, 2020. https:\/\/www.uicc.org\/news\/new-global-cancer-data-globocan-2018."},{"key":"261_CR21","doi-asserted-by":"publisher","first-page":"26282","DOI":"10.3402\/gha.v8.26282","volume":"8","author":"FC Maseko","year":"2015","unstructured":"Maseko FC, Chirwa ML, Muula AS. Health systems challenges in cervical cancer prevention program in Malawi. Glob Health Action. 2015;8:26282.","journal-title":"Glob Health Action"},{"key":"261_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/PPA.S17317","volume":"5","author":"VK Fort","year":"2011","unstructured":"Fort VK, Makin MS, Siegler AJ, Ault K, Rochat R. Barriers to cervical cancer screening in Mulanje, Malawi: a qualitative study. Patient Prefer Adher. 2011;5:125\u201331.","journal-title":"Patient Prefer Adher"},{"issue":"10","key":"261_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025481","volume":"6","author":"YT DiAngi","year":"2011","unstructured":"DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS ONE. 2011;6(10): e25481. https:\/\/doi.org\/10.1371\/journal.pone.0025481.","journal-title":"PLoS ONE"},{"key":"261_CR24","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1016\/j.vaccine.2011.07.116","volume":"29","author":"SA Francis","year":"2011","unstructured":"Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, Mofammere N. A qualitative analysis of South African women\u2019s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine. 2011;29:8760\u20135.","journal-title":"Vaccine"},{"issue":"3","key":"261_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090912","volume":"9","author":"S Perlman","year":"2014","unstructured":"Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE. 2014;9(3): e90912.","journal-title":"PLoS ONE"},{"issue":"12","key":"261_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/14760584.2018.1549994","volume":"17","author":"AB Wiyeh","year":"2018","unstructured":"Wiyeh AB, Cooper S, Nnaji CA, Wiysonge CS. Vaccine hesitancy \u2018outbreaks\u2019: using epidemiological modeling of the spread of ideas to understand the effects of vaccine related events on vaccine hesitancy. Expert Rev Vaccin. 2018;17(12):1063\u201370. https:\/\/doi.org\/10.1080\/14760584.2018.1549994.","journal-title":"Expert Rev Vaccin"},{"issue":"7\u20138","key":"261_CR27","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","volume":"15","author":"E Karafillakis","year":"2019","unstructured":"Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, Larson H. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019;15(7\u20138):1615\u201327. https:\/\/doi.org\/10.1080\/21645515.2018.1564436.","journal-title":"Hum Vaccin Immunother"},{"key":"261_CR28","unstructured":"Malawi Strategic Health Sector Strategic Plan II (2017\u20132022). Towards Universal Health Coverage. 2017, Jul. 16. Retrieved Nov. 14, 2020 from https:\/\/www.healthdatacollaborative.org\/fileadmin\/uploads\/hdc\/Documents\/Country_documents\/HSSP_II_Final_HQ_complete_file.pdf.pdf"},{"key":"261_CR29","unstructured":"Carroll AM, Perez M, Toy P, Performing a Community Assessment Curriculum, Los Angeles: UCLA Center for Health Policy Research, Health DATA Program, September 2004. Retrieved Feb 11, 2021 from: https:\/\/healthpolicy.ucla.edu\/programs\/health-data\/trainings\/Documents\/tw_cba18.pdf"},{"key":"261_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/vaccines9111231","volume":"9","author":"GC Adeyanju","year":"2021","unstructured":"Adeyanju GC, Sprengholz P, Betsch C, Essoh T-A. Caregivers\u2019 willingness to vaccinate their children against childhood diseases and human papillomavirus: a cross-sectional study on vaccine hesitancy in Malawi. Vaccines. 2021;9:1231. https:\/\/doi.org\/10.3390\/vaccines9111231.","journal-title":"Vaccines"},{"key":"261_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62:107\u201315.","journal-title":"J Adv Nurs"},{"issue":"12","key":"261_CR32","doi-asserted-by":"publisher","first-page":"e0208601","DOI":"10.1371\/journal.pone.0208601","volume":"13","author":"C Betsch","year":"2018","unstructured":"Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, B\u00f6hm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLOS ONE. 2018;13(12):e0208601. https:\/\/doi.org\/10.1371\/journal.pone.0208601.","journal-title":"PLOS ONE"},{"issue":"3","key":"261_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/vaccines1030293","volume":"1","author":"H Larson","year":"2013","unstructured":"Larson H, Leask J, Aggett S, Sevdalis N, Thomson A. A multidisciplinary research agenda for understanding vaccine-related decisions. Vaccines. 2013;1(3):293\u2013304. https:\/\/doi.org\/10.3390\/vaccines1030293.","journal-title":"Vaccines"},{"key":"261_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12889-017-4137-7","volume":"17","author":"ST Adedokun","year":"2017","unstructured":"Adedokun ST, Uthman OA, Adekanmbi VT, Wiysonge CS. Incomplete childhood immunization in Nigeria: a multilevel analysis of individual and contextual factors. BMC Public Health. 2017;17:236. https:\/\/doi.org\/10.1186\/s12889-017-4137-7.","journal-title":"BMC Public Health"},{"issue":"3","key":"261_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/21645515.2016.1243633","volume":"13","author":"LT Biasio","year":"2017","unstructured":"Biasio LT. Vaccine hesitancy and health literacy. Human Vaccin Immunother. 2017;13(3):701\u20132.","journal-title":"Human Vaccin Immunother"},{"issue":"7","key":"261_CR36","doi-asserted-by":"publisher","first-page":"e005035","DOI":"10.1136\/bmjgh-2021-005035","volume":"6","author":"P Eze","year":"2021","unstructured":"Eze P, Lawani LO, Acharya Y. Short message service (SMS) reminders for childhood immunisation in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Global Health. 2021;6(7):e005035. https:\/\/doi.org\/10.1136\/bmjgh-2021-005035.","journal-title":"BMJ Global Health"},{"key":"261_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13643-019-1054-0","volume":"8","author":"ZA Mekonnen","year":"2019","unstructured":"Mekonnen ZA, Gelaye KA, Were MC, et al. Effect of mobile text message reminders on routine childhood vaccination: a systematic review and meta-analysis. Syst Rev. 2019;8:154. https:\/\/doi.org\/10.1186\/s13643-019-1054-0.","journal-title":"Syst Rev"},{"key":"261_CR38","unstructured":"Belluz, J. Religion and vaccine refusal are linked. We have to talk about it. Vox. June 19, 2019. Retrieved June 2, 2020, from Vox: https:\/\/www.vox.com\/2019\/6\/19\/18681930\/religion-vaccine-refusal"}],"container-title":["Global Health Research and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-022-00261-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41256-022-00261-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-022-00261-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:26:54Z","timestamp":1768404414000},"score":1,"resource":{"primary":{"URL":"https:\/\/ghrp.biomedcentral.com\/articles\/10.1186\/s41256-022-00261-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1186\/s41256-022-00261-3","relation":{},"ISSN":["2397-0642"],"issn-type":[{"value":"2397-0642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"21 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval from the National Health Sciences Research Committee (NHSRC) in Malawi was received, with protocol reference number 20\/04\/2544. Also, authorization was obtained from the Malawi Ministry of Health, reference number MED\/1\/3. Informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}